RAIA, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.907
EU - Europa 1.616
AS - Asia 905
AF - Africa 35
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.469
Nazione #
US - Stati Uniti d'America 2.847
IT - Italia 706
SG - Singapore 523
CN - Cina 329
UA - Ucraina 235
FI - Finlandia 164
NL - Olanda 160
DE - Germania 119
IE - Irlanda 97
CA - Canada 58
SE - Svezia 53
GB - Regno Unito 51
CI - Costa d'Avorio 32
VN - Vietnam 25
FR - Francia 16
IR - Iran 12
IN - India 11
EG - Egitto 3
GR - Grecia 3
RO - Romania 3
TR - Turchia 3
AR - Argentina 2
BE - Belgio 2
ES - Italia 2
EU - Europa 2
AU - Australia 1
BG - Bulgaria 1
CO - Colombia 1
CY - Cipro 1
HR - Croazia 1
ID - Indonesia 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
Totale 5.469
Città #
Chandler 501
Singapore 435
Jacksonville 261
Napoli 209
Ashburn 171
Millbury 171
Naples 163
Amsterdam 156
Princeton 154
Santa Clara 125
Boston 113
Nanjing 91
Wilmington 81
Beijing 62
Ottawa 51
Des Moines 42
Houston 36
Lawrence 30
Nanchang 29
Munich 26
Shenyang 25
Dong Ket 24
Changsha 21
Norwalk 21
Hebei 19
Rome 19
Washington 19
Jiaxing 16
Orange 14
Augusta 12
Boardman 12
Falls Church 12
Mugnano Di Napoli 12
Seattle 12
Helsinki 11
Tianjin 9
Woodbridge 9
Milan 8
Villaricca 8
Dublin 7
Kronberg 7
Los Angeles 7
Redmond 7
San Mateo 7
Dallas 6
Fairfield 6
Lucca 6
New York 6
Pune 6
The Dalles 6
Ardabil 5
Bologna 5
Hangzhou 5
Leawood 5
Redwood City 5
Walnut 5
Avellino 4
Brierley Hill 4
Indiana 4
Lanzhou 4
Lappeenranta 4
Raviscanina 4
Toronto 4
Turin 4
Cairo 3
Casoria 3
Eboli 3
Formia 3
Fremont 3
Kunming 3
Marcianise 3
Marsala 3
Mugnano di Napoli 3
Selargius 3
Shanghai 3
Verona 3
Zhengzhou 3
Acerra 2
Ann Arbor 2
Barcelona 2
Basildon 2
Berlin 2
Campofelice di Roccella 2
Cattolica 2
Costa di Mezzate 2
Foggia 2
Frankfurt am Main 2
Kish 2
Marsicovetere 2
North York 2
Padova 2
Palermo 2
Parma 2
Poggiomarino 2
Sector 5 2
Sezze 2
Springfield 2
Stockholm 2
Venice 2
Altamura 1
Totale 3.407
Nome #
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 82
Clinical expression of patients with the D1152H CFTR mutation 81
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 74
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 64
Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects 60
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 56
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 56
Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis 54
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old. 53
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 53
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 53
Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? 50
Microbiology of airway disease in a cohort of patients with Cystic Fibrosis. 50
Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. 48
Chryseobacterium respiratory tract infections in patients with cystic fibrosis 48
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study 48
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. 46
Alterazioni metaboliche degli acidi grassi nella Fibrosi Cistica 46
Amines Protect Invitro the Celiac Small-intestine From the Damaging Activity of Gliadin Peptides 46
Identification of Inquilinus limosus in Cystic Fibrosis: a first report in Italy 46
An investigation on parenting stress of children with cystic fibrosis 46
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. 46
Liver expression in Cystic Fibrosis could be modulated by genetic factors different from the Cystic Fibrosis Transmembrane Regulator genotype. 45
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 45
Does virtual reality reduce pain in pediatric patients? A systematic review 45
Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration 44
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 44
Diabetes in an infant with cystic fibrosis 44
Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols 44
Metabolic interactions between cysteamine and epigallocatechin gallate 44
S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy 44
Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis 44
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. 42
7. An overview of international literature from cystic fibrosis registries. Part 4: update 2011 42
Salivary cytokines and airways disease severity in patients with cystic fibrosis 42
Effect of an 8-month treatment with omega-3 fatty acid (eicosapentanoic and docosahexaenoic) in patients with cystic fibrosis 41
Unexpected role of surface transglutaminase type II in celiac disease 41
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease 41
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. 39
A-GLIADIN RELATED SYNTHETIC PEPTIDES AGGLUTINATE UNDIFFERENTIATED K TO 562 S CELLS AND AFFECT IN VITRO DEVELOPING FETAL RAT INTESTINE AND ULTURED ATROPHIC COELIAC MUCOSA 39
Brand new SPINK1 and CFTR mutations in a child with acute recurrent pancreatitis: a case report. 39
Clinical expression of cystic fibrosis in a large cohort of Italian siblings 39
Aneuploidy of lymphocytes in familial polyposis coli. 38
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition 38
Aspergillosi broncopolmonare 38
A triphalangeal thumb associated with otological abnormalities. A new syndrome?] 37
Different mutations in mucA gene of Pseudomonasaeruginosa mucoid strains in cystic fibrosispatients and their effect on algU gene expression 37
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 37
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 37
Inhaled medications in cystic fibrosis beyond antibiotics 36
FAS engagement driver apoptosis of the enterocytes of coeliac patients 35
Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. 35
Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. 35
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis. 35
Pediatric ultrasonography of the pancreas: normal and abnormal findings 35
Epidemiologia di Burkholderia cepacia in pazienti con fibrosi cistica: primi risultati di uno studio comprendente la tipizzazione genotipica dei ceppi isolati 34
Nasal polyposis in atypical cystic fibrosis: A case report 34
Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis 34
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life 34
Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis. 34
Positive expiratory pressure treatment: efficacy in pulmonary diseases 33
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis. 33
Detection of rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype charaterization for patients with homozygote mutations. 32
Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations 32
Audit of sweat testing: a first report from Italian Cystic Fibrosis Centres 32
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. 32
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. 32
An overview of international literature from cystic fibrosis registries. Part 4: Update 2011. 32
Defective proteostasis in celiac disease as a new therapeutic target 32
First report of three cystic fibrosis patients homozygous for the 1717-1G-->A mutation. 31
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia 31
The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated 31
Lung involvement, deltaF508 mutation and DNA haplotype analysis in cystic fibrosis. 31
Cystic fibrosis: a disorder with defective autophagy 31
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 31
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease 31
Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. 31
Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis 30
Patchy expression of lactase protein in adult rabbit and rat intestine. 30
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. 30
The Italian pilot external quality assessment program for cystic fibrosis sweat test 30
Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease. 30
Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained? 29
Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia 29
Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry 29
Can Continuous Subcutaneous Insulin Infusion Improve Health-Related Quality of Life in Patients with Shwachman-Bodian-Diamond Syndrome and Diabetes? 29
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. 29
The Multifaceted Roles of MicroRNAs in Cystic Fibrosis 29
DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? 28
Epidemiology and a novel procedure for large scale :analysis of CFTR rearrangements in classic and atypical CF patients: A multicentric Italian study. 28
Italian Cystic Fibrosis Registry: 10 years of activity 28
Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study 28
An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros. 2009; 8:229-37. 28
Towards a rational combination therapy of cystic fibrosis: How cystamine restores the stability of mutant CFTR 28
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. 28
The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation 28
Molecular epidemiology of cystic fibrosis mutations and respective haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure. 27
Liver expression in cystic fibrosis could be modulated by genetic factors from the cystic fibrosis transmembrane regulator genotype 27
Positive expiratory pressure treatment: efficacy in pulmonary diseases 27
null 27
Totale 3.891
Categoria #
all - tutte 28.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020265 0 0 0 0 56 3 4 3 9 42 60 88
2020/2021630 17 48 78 64 61 76 54 9 80 12 102 29
2021/20221.038 17 5 5 0 0 158 18 41 108 58 219 409
2022/20231.220 195 122 26 77 139 125 4 122 189 149 55 17
2023/2024875 25 113 167 75 50 100 31 61 15 27 156 55
2024/2025761 244 359 14 51 93 0 0 0 0 0 0 0
Totale 5.700